1. Home
  2. PASG vs ASBP Comparison

PASG vs ASBP Comparison

Compare PASG & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Passage Bio Inc.

PASG

Passage Bio Inc.

HOLD

Current Price

$3.48

Market Cap

14.6M

Sector

Health Care

ML Signal

HOLD

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

N/A

Current Price

$7.30

Market Cap

12.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PASG
ASBP
Founded
2017
2021
Country
United States
United States
Employees
27
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.6M
12.3M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
PASG
ASBP
Price
$3.48
$7.30
Analyst Decision
Buy
Analyst Count
3
0
Target Price
★ $15.50
N/A
AVG Volume (30 Days)
13.1K
★ 27.0K
Earning Date
11-17-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.29
$3.31
52 Week High
$20.00
$367.50

Technical Indicators

Market Signals
Indicator
PASG
ASBP
Relative Strength Index (RSI) 36.41 40.25
Support Level $3.29 $7.19
Resistance Level $5.03 $8.11
Average True Range (ATR) 0.25 0.57
MACD 0.01 -0.13
Stochastic Oscillator 3.17 13.59

Price Performance

Historical Comparison
PASG
ASBP

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

About ASBP Aspire Biopharma Holdings Inc.

Aspire-Lakewood Holdings Inc is a United States-based company. Along with its subsidiary, it is involved in the design and manufacture of engineered automotive and industrial control systems that combine mechanical engineering, electronics, and computer science to provide intelligent, automated systems for vehicle electrification, safety, lightweighting, and sustainability. DCSC maintains a powertrain-agnostic product portfolio that includes mechatronic actuators, human-machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The Company operates around 11 manufacturing facilities globally and serves as a tier-one automotive supplier to OEMs and other industrial firms.

Share on Social Networks: